Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R and D Committee
Read Article
News
2024
2023
Archive
Search news articles
December 1, 2010
PEARL THERAPEUTICS’ PT003 COMBINATION THERAPY FOR COPD DEMONSTRATES SUPERIOR BRONCHODILATION COMPARED TO SPIRIVA® AND FORADIL® IN RANDOMIZED PHASE 2B STUDY
November 30, 2010
IKARIA® BEGINS ENROLLMENT OF PIVOTAL TRIAL FOR LUCASSIN®
November 8, 2010
ANAPHORE ARTICLE IN NATURE BIOTECHNOLOGY 28, 1143 (2010)
October 19, 2010
PEARL THERAPEUTICS RAISES $69 MILLION SERIES C FINANCING
October 12, 2010
UCB AND SYNOSIA THERAPEUTICS SIGN STRATEGIC ALLIANCE IN NEUROLOGY
October 12, 2010
SYNOSIA THERAPEUTICS RAISES $30M IN SERIES C FINANCING
October 8, 2010
TAKEDA AND ENVOY FORM SCHIZOPHRENIA RESEARCH ALLIANCE
September 29, 2010
SYNOSIA PRESENTS DATA FROM CLINICAL TRIAL OF SYN-118 AS A NEW TREATMENT FOR PARKINSON’S DISEASE
September 22, 2010
SEMPRUS BIOSCIENCES AWARDED $500,000 NATIONAL SCIENCE FOUNDATION GRANT
September 9, 2010
ACHAOGEN TO PRESENT NEW DATA ON ACHN-490 AT THE 50TH ANNUAL ICAAC MEETING
« Previous Page
1
…
112
113
114
115
116
…
119
Next Page »